Prasad Gawande

Prasad Gawande, PhD, currently serves as the Director of Research and Development at Quanterix, specializing in biomarkers, assay development, and system integration across various fields, including oncology and neurology. Previous roles include Vice President of Research and Development at AOA Dx, focusing on antibody engineering and diagnostics, and Director at Cleveland Diagnostics, where contributions include regulatory submissions for prostate cancer diagnostics. Experience also encompasses leadership positions at CytoChip Inc. and Theranos, as well as research positions at Genentech and Novartis. Prasad Gawande's academic background includes a PhD in Biological Chemistry and Bioengineering from the University of California, Davis, and a B.Tech in Chemical Engineering from the Institute of Chemical Technology, complemented by additional studies at The Wharton School and the Massachusetts Institute of Technology.